The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,762.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 200-unit vials of the prescription drug Botox, with a completion date of December 10, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities and veterans' medical centers. This delivery order contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products. The contract does not have a set-aside designation.
Generated 2/17/25, 9:44 PM